CCM
Callodine Capital Management Portfolio holdings
AUM
$966M
This Quarter Return
+9.3%
1 Year Return
+10.47%
3 Year Return
+39.12%
5 Year Return
+80.3%
10 Year Return
–
AUM
$331M
AUM Growth
+$331M
(+4.4%)
Cap. Flow
-$7.56M
Cap. Flow
% of AUM
-2.28%
Top 10 Holdings %
Top 10 Hldgs %
56.43%
Holding
51
New
7
Increased
17
Reduced
14
Closed
9
Top Buys
| 1 |
Crown Castle
CCI
|
$11.8M |
| 2 |
Comcast
CMCSA
|
$8.57M |
| 3 |
GSK
GSK
|
$7.38M |
| 4 |
Blackstone Secured Lending
BXSL
|
$5.2M |
| 5 |
Carlyle Group
CG
|
$3.73M |
Top Sells
| 1 |
Merck
MRK
|
$15.1M |
| 2 |
Vistra
VST
|
$9.25M |
| 3 |
Bristol-Myers Squibb
BMY
|
$6.12M |
| 4 |
Valvoline
VVV
|
$5.5M |
| 5 |
Altria Group
MO
|
$5.26M |
Sector Composition
| 1 | Financials | 53.86% |
| 2 | Healthcare | 16.13% |
| 3 | Real Estate | 9.27% |
| 4 | Consumer Staples | 5.89% |
| 5 | Consumer Discretionary | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Blackstone Secured Lending
BXSL
$6.88B
| $27.7M | 8.25% | 1,240,000 +232,772 | +23% | +$5.2M |
|
2
Sixth Street Specialty
TSLX
$2.3B
| $23.5M | 6.99% | 1,319,936 +96,186 | +8% | +$1.71M |
|
3
Viatris
VTRS
$12.3B
| $22.5M | 6.7% | 2,020,469 +299,216 | +17% | +$3.33M |
|
4
Barings BDC
BBDC
$1.04B
| $18M | 5.36% | 2,209,955 -165,045 | -7% | -$1.35M |
|
5
Radian Group
RDN
$4.72B
| $17.5M | 5.22% | 920,000 +57,500 | +7% | +$1.1M |
|
|
6
Crown Castle
CCI
$43.2B
| $17.5M | 5.22% | 129,237 +86,737 | +204% | +$11.8M |
|
7
Sanofi
SNY
$121B
| $17M | 5.05% | 350,000 +50,000 | +17% | +$2.42M |
|
8
KKR & Co
KKR
$124B
| $15.6M | 4.63% | 335,000 -15,000 | -4% | -$696K |
|
9
Equitable Holdings
EQH
$16B
| $14.9M | 4.43% | 518,602 -15,318 | -3% | -$440K |
|
10
Blue Owl Capital
OWL
$12.1B
| $12.7M | 3.79% | 1,201,918 +165,000 | +16% | +$1.75M |
|
11
Medical Properties Trust
MPW
$2.7B
| $11.8M | 3.52% | 1,060,000 +175,000 | +20% | +$1.95M |
|
|
PNNT
12
Pennant Park Investment Corp
PNNT
$468M
| $10.8M | 3.21% | 1,875,000 +36,320 | +2% | +$209K |
|
13
Lennar Class A
LEN
$34.5B
| $10.4M | 3.1% | 115,000 | – | – |
|
14
Ares Management
ARES
$39.3B
| $10.3M | 3.06% | 150,000 -75,000 | -33% | -$5.13M |
|
15
Spectrum Brands
SPB
$1.38B
| $9.14M | 2.72% | 150,000 +50,000 | +50% | +$3.05M |
|
|
16
Comcast
CMCSA
$125B
| $8.57M | 2.55% | +245,000 | New | +$8.57M |
|
|
17
GSK
GSK
$79.9B
| $7.38M | 2.2% | +210,000 | New | +$7.38M |
|
|
18
Altria Group
MO
$113B
| $7.31M | 2.18% | 160,000 -115,000 | -42% | -$5.26M |
|
19
Verizon
VZ
$186B
| $6.9M | 2.05% | 175,000 +57,500 | +49% | +$2.27M |
|
20
Blue Owl Capital
OBDC
$7.33B
| $5.78M | 1.72% | 500,000 +190,000 | +61% | +$2.19M |
|
|
21
Bristol-Myers Squibb
BMY
$96B
| $5.76M | 1.71% | 80,000 -85,000 | -52% | -$6.12M |
|
22
FS KKR Capital
FSK
$5.11B
| $5.74M | 1.71% | 328,053 -46,947 | -13% | -$822K |
|
|
23
Vistra
VST
$64.1B
| $5.37M | 1.6% | 231,351 -398,692 | -63% | -$9.25M |
|
24
Trinity Capital
TRIN
$1.14B
| $4.84M | 1.44% | 442,427 -293,141 | -40% | -$3.2M |
|
25
Gen Digital
GEN
$18.6B
| $4.1M | 1.22% | 191,217 -8,783 | -4% | -$188K |
|